Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of physcion 8-O-β-glucopyranoside on ovarian cancer cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of physcion 8-O-β-glucopyranoside on ovarian cancer cells
Authors
Keywords
-
Journal
Artificial Cells Nanomedicine and Biotechnology
Volume 47, Issue 1, Pages 2855-2865
Publisher
Informa UK Limited
Online
2019-07-13
DOI
10.1080/21691401.2019.1637884
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High long non-coding RNA NORAD expression predicts poor prognosis and promotes breast cancer progression by regulating TGF-β pathway
- (2019) Ke Zhou et al. Cancer Cell International
- Lnc RNA TPT 1‐ AS 1 promotes tumorigenesis and metastasis in epithelial ovarian cancer by inducing TPT 1 expression
- (2019) Weimin Wu et al. CANCER SCIENCE
- Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis
- (2018) Qiang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes
- (2018) Manish K. Tripathi et al. DRUG DISCOVERY TODAY
- High expression of long noncoding RNA NORAD indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer
- (2018) Qiaqia Li et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- LncRNA HOTAIR Regulates CCND1 and CCND2 Expression by Sponging miR-206 in Ovarian Cancer
- (2018) Lei Chang et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Downregulation of long noncoding RNA Sox2ot protects PC-12 cells from hydrogen peroxide-induced injury in spinal cord injury via regulating the miR-211-myeloid cell leukemia-1 isoform2 axis
- (2018) Dong Yin et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression
- (2018) Haihai Liang et al. Molecular Cancer
- miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs
- (2018) Nasha Zhang et al. LABORATORY INVESTIGATION
- Overexpression of long noncoding RNA NORAD in colorectal cancer associates with tumor progression
- (2018) Lili Wang et al. OncoTargets and Therapy
- The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608
- (2018) Zhigang Miao et al. GENE
- MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway
- (2017) Zhen Liang et al. Molecular Cancer
- Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer
- (2017) Hongzhe Li et al. Molecular Cancer
- Physcion 8-O-β-glucopyranoside suppresses the metastasis of breast cancer in vitro and in vivo by modulating DNMT1
- (2017) Xia Chen et al. Pharmacological Reports
- NORAD Expression Is Associated with Adverse Prognosis in Esophageal Squamous Cell Carcinoma
- (2017) Xiaoliang Wu et al. Oncology Research and Treatment
- Physcion 8-O-β-glucopyranoside induces mitochondria-dependent apoptosis of human oral squamous cell carcinoma cells via suppressing survivin expression
- (2016) Meng-dong Liu et al. ACTA PHARMACOLOGICA SINICA
- Physcion 8- O -β-glucopyranoside induces apoptosis, suppresses invasion and inhibits epithelial to mesenchymal transition of hepatocellular carcinoma HepG2 cells
- (2016) Qiang Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Upregulation of miR-124 by physcion 8- O -β-glucopyranoside inhibits proliferation and invasion of malignant melanoma cells via repressing RLIP76
- (2016) Di Zhang et al. BIOMEDICINE & PHARMACOTHERAPY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins
- (2016) Sungyul Lee et al. CELL
- Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
- (2016) Ian J Jacobs et al. LANCET
- Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target
- (2016) U Saini et al. ONCOGENE
- miR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor
- (2016) ZHENHUA WANG et al. ONCOLOGY REPORTS
- lncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer
- (2016) Changjie Jiao et al. ONCOLOGY REPORTS
- Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer
- (2015) Wei Wen et al. Molecular Cancer
- STAT3 Decoy Oligodeoxynucleotides-Loaded Solid Lipid Nanoparticles Induce Cell Death and Inhibit Invasion in Ovarian Cancer Cells
- (2015) Yanhui Ma et al. PLoS One
- Long noncoding RNAs in human disease: emerging mechanisms and therapeutic strategies
- (2015) Sébastien Lalevée et al. Epigenomics
- The protective effects and genetic pathways of thorn grape seeds oil against high glucose-induced apoptosis in pancreatic β-cells
- (2014) Xihu Lai et al. BMC Complementary and Alternative Medicine
- Ovarian cancer
- (2014) Gordon C Jayson et al. LANCET
- Reliable in vitro studies require appropriate ovarian cancer cell lines
- (2014) Francis Jacob et al. Journal of Ovarian Research
- Long non-coding RNAs: new players in cell differentiation and development
- (2013) Alessandro Fatica et al. NATURE REVIEWS GENETICS
- ceRNA Cross-Talk in Cancer: When ce-bling Rivalries Go Awry
- (2013) F. A. Karreth et al. Cancer Discovery
- Long non-coding RNAs and cancer: a new frontier of translational research?
- (2012) R Spizzo et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started